PAX6, a transcription factor, has currently been suggested to function as a tumor suppressor in glioblastoma and to act as an early differentitation marker for neuroendocrine cells [23], which is frequently methylated in human cancers [21,24]. Here, PAX6 is linked to neoplasm.